{"entity":{"id":"vizgen","kind":"company","name":"Vizgen","aka":[],"tldr":"Vizgen sells the MERSCOPE spatial transcriptomics platform, based on MERFISH from Xiaowei Zhuang's lab.","summary":"Vizgen, based in Cambridge, Massachusetts, sells the MERSCOPE spatial transcriptomics platform, based on the MERFISH method from Xiaowei Zhuang's laboratory. It offers single-cell resolution in situ transcriptomics and merged with Ultivue in 2025 to add protein multiplexing to the same platform. OnCo links it to spatial biology instruments. Whether combined RNA and protein spatial readouts can be standardised into tests clinicians act on, rather than remaining discovery tools, is the open question for the field. The spatial biology instruments page carries the wider picture.","asOf":"2026-09-08","links":[{"label":"Official website","url":"https://vizgen.com"}],"tags":["supporting"],"related":[],"cancers":[],"sections":["drug-discovery"],"technologies":["spatial-biology-instruments"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Cambridge, MA","country":"US","companyType":"diagnostics","website":"https://vizgen.com","investors":[],"funding":[]},"route":"/companies/vizgen/","neighbours":{"section":[{"id":"drug-discovery","kind":"section","name":"Drug Discovery Platforms","route":"/fronts/drug-discovery/"}],"technology":[{"id":"spatial-biology-instruments","kind":"technology","name":"Spatial biology instruments","route":"/technologies/spatial-biology-instruments/"}]}}